TetraGenetics Announces Discovery of Functional Antibodies Against Nav1.8 at the Antibody Engineering & Therapeutics Virtual Conference
TetraGenetics, a biopharmaceutical company developing novel antibody therapeutics for ion-channel mediated disorders, announced today that they will be presenting news of the discovery of functional antibodies against Nav1.8 at the Antibody Engineering & Therapeutics Virtual Conference taking place Dec 14th – 16th. Read more >>